A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery

Completed · Phase 1/Phase 2

Conditions studied: Inflammation Eye

In brief

Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of two dose levels of dexamethasone ophthalmic suspension eye drops to determine if the drops decrease inflammation inside the eye and are safe after cataract surgery.

Key facts

Study ID

NCT03687931

Run by

iDrop, Inc.

People needed

60

Starts

2018-08-26

Expected to finish

2019-02-28

Last updated by the study team

2019-05-24

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients at least 40 years of age scheduled for unilateral cataract surgery by phacoemulsification with posterior chamber intraocular lens implantation.

You may not qualify if…

• Patients who have received a periocular corticosteroid injection in the study eye in the 3 months prior to screening.
• Patients who anticipate requiring treatment with any corticosteroids by any route, except inhalation, during the study.
• Patients who are known steroid responders

Where it is running

• Arizona Eye Center — Chandler, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.